Notice for extraordinary shareholders meeting

This information is subject of the disclosure requirements acc. to §5-12 vphl
(Norwegian Securities Trading Act)
Nutri Pharma has today sent the attached notice to shareholders of the company.
The extraordinary meeting will be held on 12 February. The items on the agenda
refer to corporate resolutions in connection with the potential completion of
the offer for shares in Bionor Immuno AS (the "Offer"), including with respect
to contemplated private placement of minimum NOK 50 million. In addition the
agenda includes inter alia proposal for amendment of the articles of association
related to changes in the Norwegian company legislation which entered into force
in August 2009.
 
[HUG#1376274]
 
Notice for extraordinary shareholders meeting: http://hugin.info/131219/R/1376274/337831.pdf
    Notice for extraordinary shareholders meeting: http://hugin.info/131219/R/1376274/337832.pdf
    Sakkyndig redegjørelse: http://hugin.info/131219/R/1376274/337833.pdf
    Vedlegg 1 til redegjørelse: http://hugin.info/131219/R/1376274/337834.pdf